Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.400
+0.110 (3.34%)
Jul 7, 2026, 5:35 PM CET
Arterra Bioscience Market Cap
Arterra Bioscience has a market cap or net worth of €22.64 million as of July 7, 2026. Its market cap has increased by 41.67% in one year.
Market Cap
22.64M
Enterprise Value
21.56M
Revenue
4.70M
Ranking
n/a
PE Ratio
11.28
Stock Price
€3.40
Market Cap Chart
Since October 28, 2019, Arterra Bioscience's market cap has increased from 22.33M to 22.64M, an increase of 1.40%. That is a compound annual growth rate of 0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 22.64M | 12.58% |
| Dec 30, 2025 | 20.11M | 54.08% |
| Dec 30, 2024 | 13.05M | 18.07% |
| Dec 29, 2023 | 11.05M | -23.15% |
| Dec 30, 2022 | 14.38M | -24.57% |
| Dec 30, 2021 | 19.07M | 1.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.45B |
| DiaSorin | 3.70B |
| Amplifon | 2.80B |
| EL.En. | 1.40B |
| GPI S.p.A. | 424.66M |
| Svas Biosana | 48.26M |
| Talea Group | 40.74M |
| Farmacosmo | 19.41M |